Pro-Dex, Inc. (PDEX)

Pro-Dex announced the acquisition of Advanced Precision Machining on February 12, 2026, and released its fiscal 2026 second-quarter and six-month results on January 29, 2026. A three-year contract extension with its largest customer was announced on December 19, 2025, leading to a 6% jump in the stock's premarket trading. Fiscal 2026 first-quarter results were announced on October 30, 2025. The stock price increased by 1.56% between March 28, 2025, and March 27, 2026, with a high of $51.820 and a low of $43.010 in March 2026, and a year-to-date increase of 20.95%.

Information regarding the seasonality of demand for Pro-Dex, Inc.'s products and services is not specifically detailed. While there is analysis on stock price seasonality, suggesting May and April may be ideal months for positive returns, this does not directly correlate to seasonal fluctuations in product demand. The company faces risks related to fluctuating demand for technology, but a specific seasonal pattern for its products is not identified.

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device OEMs worldwide, operating in the Healthcare sector, specifically the Medical Instruments & Supplies industry. Its major products include surgical drivers and shavers used in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services, and manufactures rotary air motors for various industries, serving hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations.

Pro-Dex, Inc. is headquartered in Irvine, California, and operates manufacturing and research facilities in Irvine and Tustin, California. The company has a global distribution network across North America, Europe, and Asia, providing technical support and aftermarket services.

Pro-Dex, Inc. has built its reputation over 40 years through engineering expertise, quality management, and regulatory compliance. Its collaborations with major medical and dental product providers demonstrate credibility, responsiveness, and flexibility. The acquisition of Advanced Precision Machining and the contract extension with its largest customer have likely positively reinforced its brand reputation.

Pro-Dex, Inc.'s ownership includes institutional investors (19.91%), insiders (45.57%), and public/individual investors (34.53%). Major institutional owners include BlackRock, Inc., Vanguard Group Inc, and Dimensional Fund Advisors Lp. Nicholas John Swenson owns the most shares of Pro-Dex.